 | Up a level |
Kreuzer, Karl-Anton, Furman, Richard, Stilgenbauer, Stephan, Dubowy, Ronald, Kim, Yeonhee, Munugalavadla, Veerendra, Lilienweisz, Esther, Reinhardt, Hans Christian, Cramer, Paula, Eichhorst, Barbara, Hillmen, Peter, O'Brien, Susan, Pettitt, Andrew and Hallek, Michael (2017). Improved overall survival of relapsed chronic lymphocytic leukemia (CLL) patients exhibiting a complex karyotype and treated with idelalisib plus rituximab. Leuk. Lymphoma, 58. S. 167 - 169. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403
Soumerai, Jacob D., Ni, Ai 
ORCID: 0000-0003-3002-3556, Xing, Guan, Huang, Julie, Furman, Richard R., Jones, Jeffrey, Sharman, Jeffrey P., Hallek, Michael, Adewoye, Adeboye H., Dubowy, Ronald, Dreiling, Lyndah and Zelenetz, Andrew D.
(2019).
Evaluation of the CLL-IPI in relapsed and refractory chronic lymphocytic leukemia in idelalisib phase-3 trials.
Leuk. Lymphoma, 60 (6).
S. 1438 - 1447.
ABINGDON:
TAYLOR & FRANCIS LTD.
ISSN 1029-2403